Discard after 4 weekly doses have been given
Over the years, alemtuzumab has been used to treat lymphomas and leukemias, including T cell lymphomas, peripheral T cell lymphoma-not otherwise specified (PTCL-NOS), T cell prolymphocytic leukemia (T-PLL), cutaneous T cell lymphoma (CTCL) and adult T cell lymphoma/leukemia (ATLL) as well as B cell malignancies, such as B-cell non-Hodgkin's lymphoma (B-NHL) and B-cell chronic lymphocytic lymphoma (B-CLL)
It appears as larger patches of discoloration, typically on the cheeks, forehead, and upper lip, and is strongly linked to hormonal changes and UV exposure
However, with visibly no adverse effects, copper peptides are mild, non-hormonal, and enhance scalp health while progressively promoting hair growth
W., Lin, H